Helius Medical Technologies (NASDAQ:HSDT – Get Rating) will be announcing its Q2 earnings results after the market closes on Monday, August 15th. Analysts expect the company to announce earnings of ($1.12) per share for the quarter.
Helius Medical Technologies (NASDAQ:HSDT – Get Rating) last issued its earnings results on Thursday, May 12th. The company reported ($1.15) EPS for the quarter. Helius Medical Technologies had a negative net margin of 3,043.95% and a negative return on equity of 240.53%. The business had revenue of $0.19 million during the quarter. During the same quarter in the previous year, the company posted ($1.65) earnings per share. On average, analysts expect Helius Medical Technologies to post $-4 EPS for the current fiscal year and $-2 EPS for the next fiscal year.
Get Helius Medical Technologies alerts:Helius Medical Technologies Price Performance
Helius Medical Technologies stock opened at $0.55 on Friday. Helius Medical Technologies has a 12-month low of $0.45 and a 12-month high of $15.68. The company has a market capitalization of $2.09 million, a price-to-earnings ratio of -0.08 and a beta of 0.72. The firm's fifty day moving average price is $1.24 and its 200 day moving average price is $2.45.
About Helius Medical Technologies
(Get Rating)Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.
Featured Articles
- Get a free copy of the StockNews.com research report on Helius Medical Technologies (HSDT)
- 2 Important Retail Stock Battles to Watch
- MarketBeat: Week in Review 8/8 – 8/12
- What Is WallStreetBets and What Stocks Are They Targeting?
- Institutions And Analysts Propel Jack In The Box Higher
- Can You Guess Which EV Stock Is Beating Tesla ?
Receive News & Ratings for Helius Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helius Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.